-
Je něco špatně v tomto záznamu ?
Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis
K. Kluz, J. Parenica, L. Kubkova, S. Littnerova, J. Tomandl, M. Poloczek, O. Toman, M. Tesak, Z. Cermakova, J. Gottwaldova, J. Manousek, M. Pavkova Goldbergova, J. Spinar, J. Jarkovsky
Jazyk angličtina Země Česko
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
24457834
DOI
10.5507/bp.2014.003
Knihovny.cz E-zdroje
- MeSH
- biologické markery metabolismus MeSH
- čas zasáhnout při rozvinutí nemoci MeSH
- cévní mozková příhoda etiologie MeSH
- dospělí MeSH
- infarkt myokardu mortalita chirurgie MeSH
- Kaplanův-Meierův odhad MeSH
- koronární angioplastika * MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- natriuretický peptid typu B metabolismus MeSH
- nestabilní angina pectoris komplikace mortalita MeSH
- peptidové fragmenty metabolismus MeSH
- prognóza MeSH
- prospektivní studie MeSH
- recidiva MeSH
- senioři MeSH
- srdeční selhání etiologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
BACKGROUND: Pre-infarction unstable angina pectoris (UAP) can be considered ischemic preconditioning. The aim of this study was to compare short and long term outcomes in patients with or without pre-infarction UAP and ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). METHODS: 593 patients with STEMI (388 without and 205 with UAP) were evaluated. Levels of biomarkers (troponin I, BNP, NT-ProBNP, neopterin, endoglin and pentraxin-3) at hospital admission and 24 h after STEMI onset were assessed. Echocardiography was undertaken on the fourth day after MI and after 12 months. The median follow-up was 37 months. RESULTS: We found no significant differences in sex, age or risk factors for atherosclerosis between the UAP and non-UAP group. As the median time from the onset of chest pain to admission was significantly longer in the UAP group (228 min vs 258 min; P=0.009), we used a propensity score to obtain comparable matched groups for use in further analyses. The levels of NT-proBNP were significantly higher on admission and after 24 hours in the UAP group. Left ventricular functions according to invasive and echocardiographic parameters were entirely comparable at hospitalization and after 12 months. No differences were found in severity index of acute heart failure during hospitalization. The incidence of major acute coronary events during follow-up was comparable for the groups. CONCLUSIONS: In patients with STEMI treated with primary PCI, pre-infarction UAP has no beneficial clinical effect during hospitalization or during long-term follow-up.
Department of Biochemistry Faculty Hospital Brno
Department of Cardiology Faculty Hospital Brno
Department of Cardiology Faculty Hospital Brno Hospital Trebic Trebic Jejkov
Department of Internal Cardiology Medical Faculty Masaryk University Brno Czech Republic
Institute of Biostatistics and Analyses Masaryk University Brno
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17006077
- 003
- CZ-PrNML
- 005
- 20200720084536.0
- 007
- ta
- 008
- 170210s2015 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2014.003 $2 doi
- 035 __
- $a (PubMed)24457834
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kluz, Krystyna $u Department of Internal Cardiology, Medical Faculty, Masaryk University, Brno, Czech Republic; Hospital Podlesi a.s., Trinec $7 xx0243485
- 245 10
- $a Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis / $c K. Kluz, J. Parenica, L. Kubkova, S. Littnerova, J. Tomandl, M. Poloczek, O. Toman, M. Tesak, Z. Cermakova, J. Gottwaldova, J. Manousek, M. Pavkova Goldbergova, J. Spinar, J. Jarkovsky
- 520 9_
- $a BACKGROUND: Pre-infarction unstable angina pectoris (UAP) can be considered ischemic preconditioning. The aim of this study was to compare short and long term outcomes in patients with or without pre-infarction UAP and ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). METHODS: 593 patients with STEMI (388 without and 205 with UAP) were evaluated. Levels of biomarkers (troponin I, BNP, NT-ProBNP, neopterin, endoglin and pentraxin-3) at hospital admission and 24 h after STEMI onset were assessed. Echocardiography was undertaken on the fourth day after MI and after 12 months. The median follow-up was 37 months. RESULTS: We found no significant differences in sex, age or risk factors for atherosclerosis between the UAP and non-UAP group. As the median time from the onset of chest pain to admission was significantly longer in the UAP group (228 min vs 258 min; P=0.009), we used a propensity score to obtain comparable matched groups for use in further analyses. The levels of NT-proBNP were significantly higher on admission and after 24 hours in the UAP group. Left ventricular functions according to invasive and echocardiographic parameters were entirely comparable at hospitalization and after 12 months. No differences were found in severity index of acute heart failure during hospitalization. The incidence of major acute coronary events during follow-up was comparable for the groups. CONCLUSIONS: In patients with STEMI treated with primary PCI, pre-infarction UAP has no beneficial clinical effect during hospitalization or during long-term follow-up.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a nestabilní angina pectoris $x komplikace $x mortalita $7 D000789
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a srdeční selhání $x etiologie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a infarkt myokardu $x mortalita $x chirurgie $7 D009203
- 650 _2
- $a natriuretický peptid typu B $x metabolismus $7 D020097
- 650 _2
- $a peptidové fragmenty $x metabolismus $7 D010446
- 650 12
- $a koronární angioplastika $7 D062645
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a cévní mozková příhoda $x etiologie $7 D020521
- 650 _2
- $a čas zasáhnout při rozvinutí nemoci $7 D061665
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pařenica, Jiří $u Department of Cardiology, Faculty Hospital Brno; Department of Cardiovascular Disease, International Clinical Research Center, St. Anne´s University Hospital in Brno $7 xx0101388
- 700 1_
- $a Kubková, Lenka $u Department of Internal Cardiology, Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiology, Faculty Hospital Brno; Department of Cardiovascular Disease, International Clinical Research Center, St. Anne´s University Hospital in Brno $7 xx0241832
- 700 1_
- $a Littnerová, Simona $u Institute of Biostatistics and Analyses, Masaryk University, Brno $7 jo2012694303
- 700 1_
- $a Tomandl, Josef, $u Department of Internal Cardiology, Medical Faculty, Masaryk University, Brno, Czech Republic $d 1964- $7 mzk2003175507
- 700 1_
- $a Poloczek, Martin $u Department of Cardiology, Faculty Hospital Brno $7 xx0101387
- 700 1_
- $a Toman, Ondřej, $u Department of Cardiology, Faculty Hospital Brno $d 1974- $7 xx0082234
- 700 1_
- $a Tesák, Martin $u Department of Cardiology, Faculty Hospital Brno. Hospital Trebic, Trebic-Jejkov $7 xx0104172
- 700 1_
- $a Čermáková, Zdeňka $u Department of Biochemistry, Faculty Hospital Brno $7 xx0084249
- 700 1_
- $a Gottwaldová, Jana $u Department of Biochemistry, Faculty Hospital Brno $7 _BN006903
- 700 1_
- $a Manoušek, Jiří $u Department of Cardiology, Faculty Hospital Brno $7 _BN004708
- 700 1_
- $a Pávková Goldbergová, Monika $u Department of Internal Cardiology, Medical Faculty, Masaryk University, Brno, Czech Republic $7 xx0054290
- 700 1_
- $a Špinar, Jindřich, $u Department of Internal Cardiology, Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiology, Faculty Hospital Brno; Department of Cardiovascular Disease, International Clinical Research Center, St. Anne´s University Hospital in Brno $d 1960- $7 nlk20030128322
- 700 1_
- $a Jarkovský, Jiří $u Institute of Biostatistics and Analyses, Masaryk University, Brno $7 stk2008461294
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 2 (2015), s. 251-258
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170210 $b ABA008
- 991 __
- $a 20200720084537 $b ABA008
- 999 __
- $a ok $b bmc $g 1192602 $s 966724
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 159 $c 2 $d 251-258 $e 20140123 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20170210